Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

February 9, 2001

Pancrelipase 16,000 ECM Capsules Recalled

First public notice issued by FDA of 'completed recall'...

Philadelphia, PA (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Mutual Pharmaceutical Company, Inc. is recalling Pancrelipase 16,000 ECM Capsules, in 100 count bottles because of dissolution failure.

This is the first public notice of this Class II recall issued by FDA.

Pancrelipase 16,000 ECM Capsules, in 100 count bottles. Indicated for use for patients with pancreatic enzyme deficiency.

NDC is 53489-322-01.
Recall # D-081-1.

Lot 40629 exp. 12/00.

Mutual Pharmaceutical Company, Inc., Philadelphia, PA.

Manufacturer, by letter on October 10, 2000. FDA initiated recall *complete.

*Completed recall: While the FDA has completed processing of this particular recall, it does not necessarily mean this particular product has been fully accounted for.


3,125 bottles.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers February 9, 2001.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

SafetyAlerts compiles comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.